Sensitization of normal and malignant tissues to cyclophosphamide by nitroimidazoles with different partition coefficients
- 1 January 1984
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 49 (1) , 33-42
- https://doi.org/10.1038/bjc.1984.6
Abstract
The ability of a range of 2-nitroimidazoles with similar electron affinities but widely differing partition coefficients (P) to enhance the cytotoxicity of cyclophosphamide (CY) in mouse tumour and normal tissues was investigated. In a preliminary study large single doses of benznidazole (BENZ), misonidazole (MISO), desmethylmisonidazole (DMM), and SR-2508 were found to give similar enhancement of the RIF-1 and SCC VII/St tumours. SR-2555 was less effective. A direct comparison was made between MISO and SR-2508 using prolonged, low-level drug exposures, achieved by multiple injections. The enhancement of CY cytotoxicity achieved in the two tumour systems (RIF-1 and SCC VII/St) was found to be similar for a given blood sensitizer concentration. In the normal tissue assays (white blood cell count, bone marrow CFU-S and testis spermatogonia) neither MISO nor SR-2508 produced significant enhancement of CY cytotoxicity, so that the therapeutic gains achieved at a given blood concentration of sensitizer were similar for SR-2508 and MISO. The main advantage of SR-2508, however, will probably lie in its lower toxicity, permitting higher blood levels to be achieved. However, the slope of the dose response curves are rather shallow so we would not predict a dramatically increased benefit.Keywords
This publication has 19 references indexed in Scilit:
- Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazoleBritish Journal of Cancer, 1983
- MECHANISM OF SENSITIZATION OF CHINESE-HAMSTER OVARY CELLS TO MELPHALAN BY HYPOXIC TREATMENT WITH MISONIDAZOLE1983
- Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gainBritish Journal of Cancer, 1982
- Nitroimidazole neurotoxicity: Are mouse studies predictive?International Journal of Radiation Oncology*Biology*Physics, 1982
- The therapeutic potential of misonidazole enhancement of alkylating agent cytotoxicityInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Enhancement by electron-affinic agents of the therapeutic effects of cytotoxic agents against the KHT tumor: Structure-activity relationshipsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizersBritish Journal of Cancer, 1982
- Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamideBritish Journal of Cancer, 1981
- Structure-pharmacokinetic relationships for misonidazole analogues in miceCancer Chemotherapy and Pharmacology, 1981
- A Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow CellsRadiation Research, 1961